T. Yamamura et al., MULTIVARIATE-ANALYSIS OF THE PROGNOSTIC FACTORS OF PATIENTS WITH UNRESECTABLE SYNCHRONOUS LIVER METASTASES FROM COLORECTAL-CANCER, Diseases of the colon & rectum, 40(12), 1997, pp. 1425-1429
PURPOSE: It frequently is observed that widely varying prognoses are g
iven for patients with the same extent of liver metastases from colore
ctal cancer, even though the same treatment is performed on these pati
ents. One of the reasons for this variance is that prognostic factors
for these patients have not been defined. This study was designed to e
lucidate which clinicopathologic factors were the most important in th
e prognosis of 73 patients with unresectable synchronous liver metasta
sis from colorectal cancer. METHODS: Univariate and multivariate analy
sis of 11 clinicopathologic factors were performed using the Cox propo
rtional hazard model. Survival curves were generated using the Kaplan-
Meier method. RESULTS: Extent of liver metastases was the most signifi
cant variable in this survival analysis, although the extent of lymph
node metastases of the primary lesion also was significant. However, t
he method of treatment was not a significant determinant in the surviv
al for patients with unresectable liver metastases. Median survival of
patients with H-1, H-2, and H-3 was 13, 12, and 6 months, respectivel
y, and there was a significant difference between survival curves for
patients with H-1 and patients with H-3. Median survival of patients w
ith n(0), n(1), and n(2) was 13, 7, and 7 months respectively, and the
re was a significant difference between survival curves for patients w
ith n(0) and patients with n(2). Median survival of 6 patients with H-
1 and n(0) and of 17 patients with H-3 and n(2) was 28 and 4 months, r
espectively. There was a significant difference in survival curves bet
ween these two groups. CONCLUSION: Longevity of patients with unresect
able synchronous liver metastases from colorectal cancer is affected a
dversely by the presence of nodal metastases and extent of liver metas
tases. This should be considered in the planning treatment.